Radium-223: From Radiochemical Development to Clinical Applications in Targeted Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1874-4729|1|3|203-208

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.1, Iss.3, 2008-09, pp. : 203-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radium-223 for the treatment of prostate cancer

By Hafeez Shaista   Parker Christopher  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 3, 2013-03 ,pp. : 379-387

Informa Healthcare

Access to resources Recommend Favorite

The Evolving Clinical Role of Actinium-225 and Bismuth-213 for Targeted Alpha Therapy (TAT) - Production, Radiopharmaceutical Development and Clinical Applications

By  

Current Radiopharmaceuticals, Vol. 11, Iss. 3, 2018-12 ,pp. : 154-155

Bentham Science Publishers

Access to resources Recommend Favorite

Development of ligand-targeted liposomes for cancer therapy

By Noble Charles O   Kirpotin Dmitri B   Hayes Mark E   Mamot Christoph   Hong Keelung   Park John W   Benz Christopher C   Marks James D   Drummond Daryl C  

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 4, 2004-08 ,pp. : 335-353

Informa Healthcare

Access to resources Recommend Favorite

Development of RET Kinase Inhibitors for Targeted Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 18, Iss. 2, 2011-01 ,pp. : 162-175

Bentham Science Publishers

Access to resources Recommend Favorite

From targeted therapy in ovarian cancer to personalizing therapy for ovarian cancer

By Góómez-Raposo Céésar   Mendiola Marta   Barriuso Jorge   Hardisson David   Redondo Andréés  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 5, 2011-05 ,pp. : 591-594

Informa Healthcare

Access to resources Recommend Favorite